Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
DOW reports third-quarter results on October 22 against a backdrop of consistent analyst target-cutting, a stock trading near an index decision line, and a borrow market so loose it offers almost no squeeze fuel for bulls.
The most striking feature of the positioning setup is how one-sided the analyst community has turned. Citigroup downgraded DOW to Neutral from Buy on September 30, cutting its target from $35 to $30, while Barclays initiated coverage on October 13 with an Underweight rating and a $30 target. Mizuho, RBC Capital, and UBS all trimmed targets in late September without changing their neutral-to-cautious ratings. The consensus has settled at Sell, with the mean price target around $33, only about 11% above the current $29.93 close. That is a thin reward for a stock whose EPS momentum ranks in just the 9th percentile on a 30-day basis and the 12th percentile over 90 days. The direction of analyst travel is clearly downward, and it has accelerated heading into this print.
Bears argue the case writes itself: weakening demand across industrial and consumer end markets, persistent margin compression in polyethylene chains, elevated energy costs, and an uncertain tariff environment. Bulls point to anti-dumping protections, new production capacity, and cost reduction targets that could improve run-rate savings. JP Morgan, the most constructive major house with an Overweight and a $40 target trimmed from $42 in late July, remains an outlier on the bull side. That $40 target stands well above the pack and is worth treating with some caution relative to where the rest of the Street is clustered.
Short interest has been quietly retreating, not building, which makes the bear thesis a fundamentals story rather than a positioning one. Short interest has fallen about 12% over the past month to roughly 4.6% of the free float. Borrow costs are negligible at 0.30%, down sharply from a month ago, and availability is extremely loose, with shares available to borrow running at more than 66 times the current short interest. Nothing in the lending market suggests either short-squeeze potential or aggressive incremental bearish conviction.
Options positioning has drifted slightly more constructive than its recent norm. The put/call ratio of 0.95 runs just below its 20-day average of 0.97, and the z-score of negative 0.88 shows no meaningful divergence from recent patterns. With the stock up 5.3% over the past week and peers LYB, CE, and CF all posting similar weekly gains, the recent price action looks more like a sector-wide relief move than a DOW-specific re-rating. The last two earnings prints produced negative one-day reactions, with Q2 delivering a 4.5% decline on the day.
A separate mechanical risk sits close to the current price. ORTEX puts the probability of DOW being deleted from the CRSP US Mid index at 32% in the December 2026 quarterly review, with a secondary 28% chance of deletion from CRSP US Large. The deciding price is $29.21. DOW closed Friday at $29.93, roughly 2.5% above that level, meaning a modest post-earnings selloff could bring the stock inside the window where index tracker selling of roughly $208 million would become a factor. That flow, equivalent to about 0.8 days of normal volume, is not a certainty, but the proximity sharpens the stakes of Wednesday's print.
The October 22 release tests whether Dow's cost programme and feedstock positioning can produce results that give an increasingly cautious analyst community a reason to stop cutting targets.
See the live data behind this article on ORTEX.
Open DOW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
